돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 37356생성일: 2026년 10월 24일

4-Methylmorpholine → 6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochloride

https://huagongshe.com/ko/reaction/37356

반응식

참여 물질

역할이름HCID투입량
반응물4-MethylmorpholineHCID 7972—
반응물4-PyridinemethanamineHCID 77317—
반응물2,6-Pyridinedicarbonyl dichlorideHCID 77335—
반응물8-Chloro-dibenz[b,f]-[1,4]oxazepineHCID 838267—
용매ChloroformHCID 6212—
생성물6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochlorideHCID 131719014—

반응 단계

A solution of 8-chloro-dibenz[b,f][1,4]oxazepine (0.77 g), 2,6-pyridine-dicarbonyl chloride (0.68 g) and 4-methylmorpholine (0.367 mL) in CHCl3 (33 mL) was allowed to stand at ambient temperature for 16 hours. To this solution was added 4-(aminomethyl)pyridine (0.34 mL) and the mixture was allowed to stand at ambient temperature for 16 hours. The mixture was concentrated and the residue was extracted with ethyl acetate and saturated NaHCO3. The organic extract was concentrated and the residue chromatographed over silica gel using 50% ethyl acetate in hexane. Appropriate fractions were pooled and concentrated to give the free base of the title compound as a white solid. The HCl salt of the free base was made as described in Example 3.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05420270
출처 데이터셋uspto-grants-1995_05
ORD IDord-f8ddeab8d46441a4b8fa8589c29649fd
출처 메모uspto-grants-1995_05